Postprandial hypertriglyceridaemia in patients with Tangier disease
- PMID: 14645354
- PMCID: PMC1770132
- DOI: 10.1136/jcp.56.12.937
Postprandial hypertriglyceridaemia in patients with Tangier disease
Abstract
Background: Tangier disease (TD) is the phenotypic expression of rare familial syndromes with mutations in the ABCA1 transporter. TD results in extremely low high density lipoprotein (HDL) cholesterol and reduced low density lipoprotein cholesterol, with normal or mildly increased fasting triglyceride (TG) concentrations. Although there is a close relation between HDL cholesterol values and atherogenesis, the risk of coronary artery disease is variable in TD. Raised fasting or postprandial TG values frequently accompany low HDL cholesterol and can add to the risk of a vascular event.
Aims: To investigate the postprandial TG response in TD.
Patients and methods: Five patients (three homozygotes (HTD) and two heterozygotes (hTD)) from one family were studied. One was defined by DNA analysis as homozygous for a new mutation (C2033A) resulting in truncation of the ABCA1 protein. Their TG concentrations were measured before and four, six, and eight hours after a standardised fat load and compared with a control group.
Results: Two patients with HTD had high fasting TG concentrations. The third patient with HTD, the two with hTD, and the control group had TG concentrations within the reference range. The patients with HTD had increased postprandial peak TG values when compared with those with hTD and controls.
Conclusion: Patients with HTD, with or without fasting hypertriglyceridaemia, may have an increased TG response to a fatty meal. The small number of patients does not allow definitive conclusions to be made. However, postprandial hypertriglyceridaemia could be a reason why some patients with TD develop premature atherosclerosis.
Figures


Similar articles
-
Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.Atherosclerosis. 2006 Aug;187(2):393-400. doi: 10.1016/j.atherosclerosis.2005.09.019. Epub 2005 Oct 12. Atherosclerosis. 2006. PMID: 16225879
-
Homozygous Tangier disease and cardiovascular disease.Atherosclerosis. 1994 May;107(1):85-98. doi: 10.1016/0021-9150(94)90144-9. Atherosclerosis. 1994. PMID: 7945562 Review.
-
Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.J Clin Endocrinol Metab. 2000 Dec;85(12):4575-82. doi: 10.1210/jcem.85.12.7037. J Clin Endocrinol Metab. 2000. PMID: 11134111 Clinical Trial.
-
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.Mol Genet Metab. 2012 Nov;107(3):534-41. doi: 10.1016/j.ymgme.2012.08.005. Epub 2012 Aug 18. Mol Genet Metab. 2012. PMID: 22959828
-
Reduced platelet count, but no major platelet function abnormalities, are associated with loss-of-function ATP-binding cassette-1 gene mutations.Clin Sci (Lond). 2017 Jul 24;131(16):2095-2107. doi: 10.1042/CS20170195. Print 2017 Aug 15. Clin Sci (Lond). 2017. PMID: 28634189 Review.
Cited by
-
The link between human and transgenic animal studies involving postprandial hypertriglyceridemia and CETP gene polymorphisms.Open Cardiovasc Med J. 2009 Jun 11;3:48-50. doi: 10.2174/1874192400903010048. Open Cardiovasc Med J. 2009. PMID: 19557147 Free PMC article. No abstract available.
-
Quantile-dependent expressivity of postprandial lipemia.PLoS One. 2020 Feb 26;15(2):e0229495. doi: 10.1371/journal.pone.0229495. eCollection 2020. PLoS One. 2020. PMID: 32101585 Free PMC article.
-
Hepatic ABCA1 and VLDL triglyceride production.Biochim Biophys Acta. 2012 May;1821(5):770-7. doi: 10.1016/j.bbalip.2011.09.020. Epub 2011 Oct 6. Biochim Biophys Acta. 2012. PMID: 22001232 Free PMC article. Review.
-
Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia.Vasc Health Risk Manag. 2005;1(2):155-61. doi: 10.2147/vhrm.1.2.155.64079. Vasc Health Risk Manag. 2005. PMID: 17315402 Free PMC article.
-
Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids.Front Physiol. 2023 Aug 4;14:1208719. doi: 10.3389/fphys.2023.1208719. eCollection 2023. Front Physiol. 2023. PMID: 37601634 Free PMC article.
References
-
- Fredrickson DS, Altrocehi PH, Avioli LV, et al. Tangier disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med 1961;55:1016–31.
-
- Brooks-Wilson A, Marcil M, Clee SM, et al. Mutation in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336–45. - PubMed
-
- Rust S, Rosier M, Funke H, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999;22:352–5. - PubMed
-
- Bodzioch M, Orsó E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999;22:347–51. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous